Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Alemtuzumab for multiple sclerosis.
Optic neuritis: A blurry issue.
Disease-Modifying Therapy of Pediatric Multiple Sclerosis.
Neuromyelitis optica antibody in Leber hereditary optic neuropathy: case report.
Activated Invariant NKT Cells Control Central Nervous System Autoimmunity in a Mechanism That Involves Myeloid-Derived Suppressor Cells.
Exposure to anaesthetic agents does not affect multiple sclerosis risk.
Association of methylenetetrahydrofolate reductase A1298C polymorphism but not of C677T with multiple sclerosis in Tunisian patients.
Structural and Dynamical Insights on HLA-DR2 Complexes That Confer Susceptibility to Multiple Sclerosis in Sardinia: A Molecular Dynamics Simulation Study.
Association of SNPs of CD40 Gene with Multiple Sclerosis in Russians.
Gut dysfunction in patients with multiple sclerosis and the role of spinal cord involvement in the disease.
Resident glial cell activation in response to perispinal inflammation leads to acute changes in nociceptive sensitivity: implications for the generation of neuropathic pain.
Initial investigation of the blood-brain barrier in MS lesions at 7 tesla.
Anti-interleukin-2 receptor alpha for multiple sclerosis?
Reports of Patients and Relatives from the CogniCIS Study about Cognition in Clinically Isolated Syndrome: What Are Our Patients Telling Us?
Suicidal Behavior and Neurological Illnesses.
Multiple Sclerosis: Improved Identification of Disease-relevant Changes in Gray and White Matter Using Susceptibility-based MR Imaging.
Glatiramer acetate to treat multiple sclerosis during pregnancy and lactation: a safety evaluation.
Simvastatin in patients with progressive multiple sclerosis--Authors' reply.
Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033.
Accuracy of a custom physical activity and knee angle measurement sensor system for patients with neuromuscular disorders and gait abnormalities.
Expanded CD8 T-cell sharing between periphery and CNS in multiple sclerosis.
Meta-analysis of prevalence.
A Randomized, Double-Blind, Placebo-Controlled Trial of Duloxetine for the Treatment of Pain in Patients with Multiple Sclerosis.
Multiple sclerosis: Lessons from molecular neuropathology.
Colour vision impairment is associated with disease severity in multiple sclerosis.
Pages
« first
‹ previous
…
360
361
362
363
364
365
366
367
368
…
next ›
last »